These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 24148693)

  • 21. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia in amyotrophic lateral sclerosis.
    Dewil M; Van Den Bosch L; Robberecht W
    Acta Neurol Belg; 2007 Sep; 107(3):63-70. PubMed ID: 18072333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of cell therapy for amyotrophic lateral sclerosis.
    Garbuzova-Davis S; Sanberg PR
    Exp Neurol; 2009 Mar; 216(1):3-6. PubMed ID: 19084005
    [No Abstract]   [Full Text] [Related]  

  • 24. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem therapy for ALS: hope and reality.
    Silani V; Leigh N
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):8-10. PubMed ID: 12745611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introducing Amyotrophic lateral sclerosis.
    Silani V; Meininger V; Fornai F
    Arch Ital Biol; 2011 Mar; 149(1):1-4. PubMed ID: 21412712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
    Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
    Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular therapies in motor neuron diseases.
    Nayak MS; Kim YS; Goldman M; Keirstead HS; Kerr DA
    Biochim Biophys Acta; 2006; 1762(11-12):1128-38. PubMed ID: 16872810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.
    Goutman SA; Savelieff MG; Sakowski SA; Feldman EL
    Expert Opin Investig Drugs; 2019 Jun; 28(6):525-543. PubMed ID: 31189354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance.
    Przedborski S
    Neurologist; 2004 Jan; 10(1):1-7. PubMed ID: 14720310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons.
    Subramanian V; Crabtree B; Acharya KR
    Hum Mol Genet; 2008 Jan; 17(1):130-49. PubMed ID: 17916583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells in the treatment of amyotrophic lateral sclerosis (ALS).
    Silani V; Fogh I; Ratti A; Sassone J; Ciammola A; Cova L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):173-81. PubMed ID: 12710505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental models of amyotrophic lateral sclerosis.
    Elliott JL
    Neurobiol Dis; 1999 Oct; 6(5):310-20. PubMed ID: 10527800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.
    Suzuki M; Svendsen CN
    Trends Neurosci; 2008 Apr; 31(4):192-8. PubMed ID: 18329734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational stem cell therapy for amyotrophic lateral sclerosis.
    Boulis NM; Federici T; Glass JD; Lunn JS; Sakowski SA; Feldman EL
    Nat Rev Neurol; 2011 Dec; 8(3):172-6. PubMed ID: 22158518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The past, present and future of stem cell clinical trials for ALS.
    Thomsen GM; Gowing G; Svendsen S; Svendsen CN
    Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy.
    Naganska E; Matyja E
    Folia Neuropathol; 2011; 49(1):1-13. PubMed ID: 21455838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis.
    Corti S; Nizzardo M; Nardini M; Donadoni C; Salani S; Simone C; Falcone M; Riboldi G; Govoni A; Bresolin N; Comi GP
    Hum Mol Genet; 2010 Oct; 19(19):3782-96. PubMed ID: 20650960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.